Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Pharmacelera logo — Mine enhanced chemical space. Design superior candidates

Pharmacelera

Mine enhanced chemical space. Design superior candidates

Founded 2015 Spain Spain 28 employees Seed Total: $3.61M Biotechnology, Information Technology +3

General Information

Company Name Pharmacelera
Founded Year 2015
Location Spain Spain
Employees 28
Industries Biotechnology, Information Technology, Life Sciences +2
Funding Stage Seed
Business Model B2B, SaaS, Platform
Revenue Model Licensing, Project Based
Social

BounceWatch is an independent company data service, not affiliated with Pharmacelera. To contact Pharmacelera, visit pharmacelera.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Pharmacelera compare?

A PDF of Pharmacelera and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Pharmacelera soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Pharmacelera

Pharmacelera is a pioneering entity established in 2015 that operates at the intersection of Biotechnology, Information Technology, Life Sciences, Pharmaceuticals, and Machine Learning. Headquartered in Spain, the company presents a unique value proposition by leveraging Quantum-Mechanics and Machine Learning to drive its drug discovery process.

The company develops proprietary Computer-Aided Drug Design software, offering it through flexible licensing and services. This approach allows exploration of a vast unexploited chemical space, bridging a gap in pharmaceutical research with diverse chemical compounds. The technology stems from over 25 years of research, supporting stages from Target Identification to Lead Optimization.

Recently, Pharmacelera secured a €1.60M seed round investment from General Inception as of April 2023, empowering it to further innovate and provide robust computational chemistry solutions.

Business keywords: Quantum Mechanics, Computer-Aided Drug Design, High-Performance Computing, Drug Discovery, Computational Chemistry, Ligand-Based Drug Design, Virtual Screening, 3D Quantitative Structure-Activity Relationship, Molecular Modeling, Target Identification, Hit Identification, Lead Optimization, Quantum Chemistry, Licensing Options

Services & Products

Target Identification
Hit Identification
Lead Optimization
Consultation and Collaboration in Drug Design
Provision of Proprietary Software Solutions

Target Customers

Small Biotech Companies Big Pharmaceutical R&D Departments Public Research Institutions Contract Research Organizations (CROs)

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round €1.60M 1
General Inception
General Inception
01 Apr 2023
Grant €960.00K -
15 Mar 2020
Seed Round €625.00K 1
The Collider
The Collider
19 Mar 2019
Grant €425.00K -
15 Mar 2018

Pharmacelera Alternatives & Competitors

View All Alternatives
Pharmacelera vs
Molecular Forecaster
Molecular Forecaster Canada

Pioneers of Research-as-a-Service: bringing computer-aided drug design software and services to biot...

20 employees
Biotechnology, Life Sciences
Compare Pharmacelera vs Molecular Forecaster
Pharmacelera vs
Anyo Labs
Anyo Labs Sweden

Anyo holds the world’s most efficient small molecular drug engineering tools. Enabling the next fro...

Pre-Seed
13 employees
AI, Biotechnology
Compare Pharmacelera vs Anyo Labs
Pharmacelera vs
Accutar Biotech
Accutar Biotech United States

Employ AI to Revolutionize Drug Discovery

Venture round
40 employees
AI, Biopharma
Also compare with: Pharmacelera vs CrystalsFirst CrystalsFirst View all alternatives

FAQ About Pharmacelera

Mine enhanced chemical space. Design superior candidates
Pharmacelera was founded in 2015.
Pharmacelera is headquartered in Spain.
Pharmacelera operates in Biotechnology, Information Technology, Life Sciences, Pharmaceutical and Machine Learning. Its work centres on Quantum Mechanics, Computer-Aided Drug Design, High-Performance Computing and Drug Discovery. Its customers include Small Biotech Companies, Big Pharmaceutical R&D Departments and Public Research Institutions.
Pharmacelera has a B2B, SaaS and Platform business model. Its revenue comes from Licensing and Project Based.
Pharmacelera has approximately 28 employees.
Pharmacelera has completed 4 funding rounds, raising a total of $3.61M. The latest funding stage is Seed.
Pharmacelera offers: Target Identification, Hit Identification, Lead Optimization, Consultation and Collaboration in Drug Design, Provision of Proprietary Software Solutions.
Top alternatives and competitors to Pharmacelera include Molecular Forecaster, Anyo Labs, Accutar Biotech, SARomics Biostructures AB, HTuO Biosciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Pharmacelera and Molecular Forecaster are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Pharmacelera, https://bouncewatch.com/company/pharmacelera, updated 15 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes